Clinical Trial Update: Treating Insulin Resistance as a Strategy to Improve Outcome in Refractory Bipolar Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating treating insulin resistance to improve outcomes in refractory bipolar disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Snippet

Sponsor: Cynthia Calkin | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED